FI823723L - Antraniloyloxialkanoater - Google Patents

Antraniloyloxialkanoater

Info

Publication number
FI823723L
FI823723L FI823723A FI823723A FI823723L FI 823723 L FI823723 L FI 823723L FI 823723 A FI823723 A FI 823723A FI 823723 A FI823723 A FI 823723A FI 823723 L FI823723 L FI 823723L
Authority
FI
Finland
Prior art keywords
alkyl
phenethyl
phenyl
anthraniloyloxyalkanoates
benzoylethyl
Prior art date
Application number
FI823723A
Other languages
English (en)
Other versions
FI823723A0 (fi
Inventor
Dante Nardi
Gianni Motta
Rodolfo Testa
Gabriele Graziani
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of FI823723A0 publication Critical patent/FI823723A0/fi
Publication of FI823723L publication Critical patent/FI823723L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/52Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)
FI823723A 1981-11-14 1982-11-01 Antraniloyloxialkanoater FI823723L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8134398 1981-11-14

Publications (2)

Publication Number Publication Date
FI823723A0 FI823723A0 (fi) 1982-11-01
FI823723L true FI823723L (fi) 1983-05-15

Family

ID=10525904

Family Applications (1)

Application Number Title Priority Date Filing Date
FI823723A FI823723L (fi) 1981-11-14 1982-11-01 Antraniloyloxialkanoater

Country Status (19)

Country Link
US (1) US4482561A (fi)
EP (1) EP0079740B1 (fi)
JP (1) JPS58135882A (fi)
AT (1) ATE16490T1 (fi)
AU (1) AU9045382A (fi)
CA (1) CA1193260A (fi)
DE (1) DE3242196A1 (fi)
DK (1) DK485282A (fi)
ES (1) ES8404685A1 (fi)
FI (1) FI823723L (fi)
GR (1) GR77367B (fi)
HU (1) HU188224B (fi)
IL (1) IL67194A (fi)
IT (1) IT1196425B (fi)
NL (1) NL8204384A (fi)
NO (1) NO823659L (fi)
NZ (1) NZ202320A (fi)
PT (1) PT75834B (fi)
ZA (1) ZA828234B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3742580C1 (de) * 1987-12-16 1989-05-11 Schaper & Bruemmer Gmbh Verwendung des alpha,alpha-Diphenyl-alpha-(3-carboxy-propionyloxy)-essigsaeure-4-(N-methylpiperidyl)-esters zur Behandlung hypertoner Funktionszustaende im Bereich der Harnblase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE589546A (fi) * 1959-04-15
FR6103M (fi) * 1967-02-22 1968-06-10
FR6195M (fi) * 1967-04-11 1968-07-22
FR2434808A1 (fr) * 1978-09-01 1980-03-28 Science Union & Cie Nouveaux esters du methyl-1 piperidinol-4, leur procede de preparation et les compositions pharmaceutiques les renfermant
FR2467846A1 (fr) * 1979-10-22 1981-04-30 Dufour J C Nouveaux b hydroxy esters de piperidyle

Also Published As

Publication number Publication date
HU188224B (en) 1986-03-28
ATE16490T1 (de) 1985-11-15
US4482561A (en) 1984-11-13
ZA828234B (en) 1983-09-28
ES517062A0 (es) 1984-05-16
NL8204384A (nl) 1983-06-01
JPS58135882A (ja) 1983-08-12
EP0079740B1 (en) 1985-11-13
NZ202320A (en) 1985-05-31
IT1196425B (it) 1988-11-16
CA1193260A (en) 1985-09-10
AU9045382A (en) 1983-05-19
DK485282A (da) 1983-05-15
GR77367B (fi) 1984-09-11
DE3242196A1 (de) 1983-05-26
IL67194A0 (en) 1983-03-31
EP0079740A1 (en) 1983-05-25
IL67194A (en) 1986-04-29
NO823659L (no) 1983-05-16
FI823723A0 (fi) 1982-11-01
PT75834A (en) 1982-12-01
PT75834B (en) 1985-11-12
IT8224204A0 (it) 1982-11-11
ES8404685A1 (es) 1984-05-16

Similar Documents

Publication Publication Date Title
HUP0100472A2 (hu) Új aminok, mint gyógyászati szerek
AR021355A1 (es) Derivados de quinolina. procedimiento para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la fabricacion de unmedicamento
DK188288A (da) 1-phenyl-3-naphthalenyloxypropanaminer, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske midler indeholdende disse
DK0464465T3 (da) Substituerede aminoalkylbiphenylderivater, antimykotiske præparater indeholdende disse derivater og mellemprodukter til fremstilling deraf
DK234388A (da) 1,4-dihydropyridin-forbindelser, farmaceutiske praeparater indeholdende disse og deres anvendelse til deres fremstilling af laegemidler samt beskyttede derivater deraf til anvendelse som udgangsmateriale ved deres fremstilling
PT87073A (pt) 4-]4-]4-]4-]]2-(2,4-difluorophenyl)-2-(1h-azolylmethyl)-1,3-dioxolan-4-yl"methoxy"phenyl"-1-piperazinyl"phenyl"triazolones
EA200200489A1 (ru) Новые соединения бензотиадиазина, способ их получения и содержащие их фармацевтические композиции
SE8802412L (sv) Tiokarbamidderivat
DK0902684T3 (da) Hexahydro-pyrido (4,3-B) indolderivater som antipsykotiske lægemidler
ATE102199T1 (de) 4-amino-3-carboxynaphthyridin-derivate, ihre herstellung und pharmazeutische zusammensetzungen.
HUP0300295A2 (hu) Helyettesített benzamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DK0461958T3 (da) 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf i terapien
IT1196425B (it) Antraniloilossialcanoati
HUP0003689A2 (hu) Endotelin antagonista benzotiazin-dioxid-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás ismert származékok előállítására
DK0648202T3 (da) Substituerede (arylalkylaminobenzyl)aminopropanamidderivater, fremstilling deraf og anvendelse som anti-epileptiske, neurobeskyttende og antidepressive midler
ES2165410T3 (es) Nuevas 5-(ariloxi-metil)-oxazolinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
DK163783D0 (da) Fremgangsmade til fremstilling af imidazolinderivater
BR0013375A (pt) Composições farmacêuticas contendo derivados tiazolidinodiona e processo para sua preparação
DK158729C (da) N-(3-trifluormethylphenyl)-n'-propargylpiperazin, farmaceutiske praeparater, der indeholder det, dets anvendelse, samt en fremgangsmaade til fremstilling af et farmaceutisk praeparat
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
DK356287A (da) 2,6-piperazindionderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
DK158002C (da) Pyridooe2,1-baaquinazolin-derivater, farmaceutisk e praeparater indeholdende disse og anvendelse af disse
BR9902841A (pt) Compostos de 8h-tieno-{2,3-b}pirrolizin-8-ona, processo para suas preparações e composições farmacêuticas contendo os mesmos
DE3370627D1 (de) Acridanone derivatives
TH127941A (th) อนุพันธ์อะมิโนไธแอโซล การเตรียมอนุพันธ์เหล่านี้ และองค์ประกอบทางเภสัชกรรมที่มีอนุพันธ์เหล่านี้

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: RECORDATI S.A., CHEMICAL AND